Shortcuts 2020 2018 2017 2016 2014 2013

2020

  • BioTuesdays
    BioCardia developing autologous and allogenic cardiovascular cell therapies Read More

  • Pharmaceutical Technology
    BioCardia’s novel CardiAMP stem cell therapy closer to approval in heart failure Read More

  • The Big Biz show
    The Big Biz Show interviews BioCardia CEO, Peter Altman Read More

2018

  • Cardiology Today
    Ongoing trial assessing novel assay to determine response to cardiac regenerative therapy Read More

  • University of Minnesota
    Investigational Therapy Exploring Treatment of Heart Failure Seeks to Stimulate Body’s Natural Healing Response Read More

  • BioWorld Med Tech
    Biocardia wins IDE for cell therapy as treatment for angina Read More

2017

  • BioWorld Med Tech
    Biocardia presses on with Cardiamp pivotal trial to treat patients with heart failure Read More

  • Med Latest
    BioCardia® Helix Results in Higher Stem Cell Retention in Myocardium Read More

  • Fox 47
    UW Health trial involves injecting stem cells into patients with heart failure Read More

  • Medical press
    First participant treated in trial of stem-cell therapy for heart failure Read More

  • Cardiology today
    First patient treated in trial of novel cell therapy Read More

  • News Center Watch
    Johns Hopkins, MSCRF, BioCardia treat first patient with CardiAMP in ischemic heart failure trial Read More

  • Drug Delivery
    BioCardia, Johns Hopkins treats first patient with CardiAmp cell therapy in Phase III trial Read More

  • The Baltimore Sun
    Patient's own bone marrow used to treat heart failure Read More

2016

  • Drug Delivery
    BioCardia launches pivotal trial for CardiAmp heart failure treatment Read More

  • Cardiac Interventions
    Studies Presented for BioCardia’s CardiAMP Cell Therapy Read More

2014

  • Cardiology today
    Clinical trial will explore bone marrow-derived cell therapy for HF Read More

  • FDA NEWS
    FDA OKs Phase III Trial of Cell-Based Heart Failure Therapy and Diagnostic Read More

2013

  • DAIC
    Phase II TAC-HFT Trial Suggests Efficacy for Transendocardial Delivery of Autologous Cells for Ischemic Heart Failure Read More

News

15 Sep

BioTuesdays

BioCardia developing autologous and allogenic cardiovascular cell therapies
Read More
03 Aug

Pharmaceutical Technology

BioCardia’s novel CardiAMP stem cell therapy closer to approval in heart failure
Read More
28 Jul

The Big Biz show

The Big Biz Show interviews BioCardia CEO, Peter Altman
Read More
28 Oct

Cardiology Today

Ongoing trial assessing novel assay to determine response to cardiac regenerative therapy
Read More
11 May

University of Minnesota

Investigational Therapy Exploring Treatment of Heart Failure Seeks to Stimulate Body’s Natural Healing Response
Read More
31 Jan

BioWorld Med Tech

Biocardia wins IDE for cell therapy as treatment for angina
Read More

press releases

26 Aug
2020 BioCardia to Present at the LD Micro 500 Virtual Conference on September 1, 2020
13 Aug
2020 BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
07 Aug
2020 BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020
01 Jul
2020 BioCardia Announces Activation of Pivotal Trial Studying CardiAMP Cell Therapy Trial to Treat Chronic Myocardial Ischemia
29 Jun
2020 BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era
17 Jun
2020 BioCardia Announces Pricing of $10.0 Million Public Offering
Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.
CLINICAL TRIALS